Inspire Medical Systems (NYSE:INSP – Get Free Report) updated its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.10-0.20 for the period, compared to the consensus earnings per share estimate of ($0.32). The company issued revenue guidance of $783-793 million, compared to the consensus revenue estimate of $782.27 million.
Inspire Medical Systems Stock Performance
Shares of INSP stock traded down $81.16 during mid-day trading on Wednesday, reaching $164.47. 4,645,146 shares of the company’s stock traded hands, compared to its average volume of 567,926. Inspire Medical Systems has a 12 month low of $123.27 and a 12 month high of $330.00. The firm has a 50 day moving average price of $215.68 and a two-hundred day moving average price of $190.38. The firm has a market capitalization of $4.98 billion, a PE ratio of -222.26 and a beta of 1.35.
Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.34) EPS for the quarter, topping analysts’ consensus estimates of ($0.63) by $0.29. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The business had revenue of $164.01 million during the quarter, compared to analysts’ expectations of $161.41 million. During the same quarter in the prior year, the business posted ($0.53) earnings per share. The business’s quarterly revenue was up 28.2% on a year-over-year basis. As a group, equities analysts expect that Inspire Medical Systems will post -0.35 earnings per share for the current fiscal year.
Analyst Ratings Changes
View Our Latest Report on Inspire Medical Systems
Insider Buying and Selling
In related news, Director Jerry C. Griffin sold 554 shares of the firm’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $198.05, for a total value of $109,719.70. Following the transaction, the director now directly owns 9,744 shares of the company’s stock, valued at approximately $1,929,799.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Jerry C. Griffin sold 554 shares of the stock in a transaction on Monday, March 11th. The stock was sold at an average price of $198.05, for a total value of $109,719.70. Following the completion of the transaction, the director now directly owns 9,744 shares of the company’s stock, valued at approximately $1,929,799.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Randy Ban sold 3,060 shares of Inspire Medical Systems stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $182.01, for a total transaction of $556,950.60. Following the sale, the insider now directly owns 3,029 shares in the company, valued at approximately $551,308.29. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,371 shares of company stock valued at $15,664,278. 4.10% of the stock is owned by corporate insiders.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Recommended Stories
- Five stocks we like better than Inspire Medical Systems
- How to Choose Top Rated Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What is the Dow Jones Industrial Average (DJIA)?
- Generac Powers Ahead on the Electrification Mega-Trend
- How Technical Indicators Can Help You Find Oversold StocksÂ
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.